Drug profile · INN
samarium sm-153 lexidronam pentasodium
QUADRAMET
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
samarium sm-153 lexidronam pentasodium (QUADRAMET) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN samarium sm-153 lexidronam pentasodium
Brand QUADRAMET
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is samarium sm-153 lexidronam pentasodium?
samarium sm-153 lexidronam pentasodium (QUADRAMET) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for samarium sm-153 lexidronam pentasodium?
QUADRAMET is a marketed brand name for samarium sm-153 lexidronam pentasodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of samarium sm-153 lexidronam pentasodium?
samarium sm-153 lexidronam pentasodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.